Literature DB >> 8543593

mRNA levels of nm23 in murine ascites hepatoma (H22) clones with different lymphatic metastatic potential.

X P Jiang1, Z Y Tang, K D Liu, X D Zhou, Z Y Lin, M Y Ling, X F Wu.   

Abstract

Levels of expression of the nm23 gene inversely correlated with metastatic potential in several rodent tumor model systems and human breast carcinoma. In the present study, we examined nm23 mRNA levels in two murine ascites hepatoma models (H22-16A3-F and H22-A2-P) with different metastatic potentials. Metastatic H22-16A3-F (80% metastatic rate) and non-metastatic H22-A2-P clones were both derived from murine ascites hepatoma (H22). We found that a 0.8-kb nm23 transcript was expressed in both cell clones. The nm23 gene was expressed at a higher level in non-metastatic H22-A2-P: approximately 8.6-fold higher than in metastatic H22-16A3-F. The present data suggest that the expression of nm23 mRNA might be associated with metastasis of murine ascites hepatoma (H22), though heterogeneity of nm23 steady-state expression levels among the H22 clones remains to be investigated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8543593     DOI: 10.1007/bf01203073

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  18 in total

Review 1.  Suppressors of the malignant phenotype.

Authors:  T Mikkelsen; W K Cavenee
Journal:  Cell Growth Differ       Date:  1990-04

2.  Clues to the function of Nm23 and Awd proteins in development, signal transduction, and tumor metastasis provided by studies of Dictyostelium discoideum.

Authors:  L A Liotta; P S Steeg
Journal:  J Natl Cancer Inst       Date:  1990-07-18       Impact factor: 13.506

3.  Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis.

Authors:  P S Steeg; G Bevilacqua; R Pozzatti; L A Liotta; M E Sobel
Journal:  Cancer Res       Date:  1988-11-15       Impact factor: 12.701

4.  New role for gene linked to metastasis suppression?

Authors:  J Marx
Journal:  Science       Date:  1993-07-23       Impact factor: 47.728

5.  Somatic allelic deletion of nm23 in human cancer.

Authors:  A Leone; O W McBride; A Weston; M G Wang; P Anglard; C S Cropp; J R Goepel; R Lidereau; R Callahan; W M Linehan
Journal:  Cancer Res       Date:  1991-05-01       Impact factor: 12.701

6.  Dictyostelium nucleoside diphosphate kinase highly homologous to Nm23 and Awd proteins involved in mammalian tumor metastasis and Drosophila development.

Authors:  V Wallet; R Mutzel; H Troll; O Barzu; B Wurster; M Veron; M L Lacombe
Journal:  J Natl Cancer Inst       Date:  1990-07-18       Impact factor: 13.506

7.  Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis.

Authors:  E H Postel; S J Berberich; S J Flint; C A Ferrone
Journal:  Science       Date:  1993-07-23       Impact factor: 47.728

Review 8.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

9.  Identification of a second human nm23 gene, nm23-H2.

Authors:  J A Stahl; A Leone; A M Rosengard; L Porter; C R King; P S Steeg
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

10.  [Cloning and sequencing of nm23-H3b, a new gene identified to nm23].

Authors:  X P Jiang; K D Liu; X D Zhou
Journal:  Zhonghua Yi Xue Za Zhi       Date:  1994-11
View more
  3 in total

Review 1.  Hepatocellular carcinoma--cause, treatment and metastasis.

Authors:  Z Y Tang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Effect of hepatoma H22 on lymphatic endothelium in vitro.

Authors:  Hua Yu; Hong-Zhi Zhou; Chun-Mei Wang; Xiao-Ming Gu; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

Review 3.  Nm23/NDP kinases in hepatocellular carcinoma.

Authors:  Mathieu Boissan; Marie-Lise Lacombe
Journal:  J Bioenerg Biomembr       Date:  2006-08       Impact factor: 3.853

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.